Panagora Asset Management Inc Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Panagora Asset Management Inc

$19.7 Billion
Q2 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$144.95 - $152.29 $261,199 - $274,426	1,802 New	1,802 $272,000
Q4 2021 Feb 10, 2022	SELL	$99.73 - $148.48 $259,397 - $386,196	-2,601 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$98.85 - $138.91 $4,052 - $5,695	-41 Reduced 1.55%	2,601 $361,000
Q2 2021 Aug 11, 2021	BUY	$65.78 - $105.02 $33,218 - $53,035	505 Added 23.63%	2,642 $256,000
Q1 2021 May 12, 2021	SELL	$64.07 - $91.75 $5.03 Million - $7.2 Million	-78,470 Reduced 97.35%	2,137 $146,000
Q4 2020 Feb 10, 2021	SELL	$65.07 - $98.24 $78,083 - $117,888	-1,200 Reduced 1.47%	80,607 $6.91 Million
Q3 2020 Nov 13, 2020	SELL	$59.04 - $77.95 $1.33 Million - $1.75 Million	-22,501 Reduced 21.57%	81,807 $5.32 Million
Q2 2020 Aug 12, 2020	BUY	$29.01 - $74.23 $74,497 - $190,622	2,568 Added 2.52%	104,308 $7.63 Million
Q1 2020 May 14, 2020	SELL	$27.51 - $57.29 $5.74 Million - $12 Million	-208,699 Reduced 67.23%	101,740 $3.46 Million
Q4 2019 Feb 12, 2020	BUY	$40.86 - $57.65 $2.04 Million - $2.88 Million	49,908 Added 19.16%	310,439 $16.9 Million
Q3 2019 Nov 12, 2019	BUY	$37.38 - $49.47 $973,562 - $1.29 Million	26,045 Added 11.11%	260,531 $10.9 Million
Q2 2019 Aug 09, 2019	BUY	$39.79 - $67.01 $9.33 Million - $15.7 Million	234,486 New	234,486 $10.3 Million
Q4 2018 Feb 14, 2019	SELL	$29.75 - $42.9 $799,680 - $1.15 Million	-26,880 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$32.79 - $43.0 $881,395 - $1.16 Million	26,880 New	26,880 $1.01 Million
Q1 2018 May 15, 2018	SELL	$22.49 - $34.56 $552,084 - $848,378	-24,548 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$23.54 - $38.21 $577,859 - $937,979	24,548	24,548 $918,000

Others Institutions Holding BHVN

# of Institutions

Shares Held

785K

Call Options Held

Put Options Held

View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

More about BHVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.

Account